NCT03213808 - "VALIDATION OF THE CHAPTER ALLERGIES AND HYPERSENSITIVITY OF THE INTERNATIONAL DISEASE CLASSIFICATION (CIM)" | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

July 10, 2017

Primary Completion Date

September 1, 2018

Study Completion Date

September 1, 2019

Conditions

ALLERGIC OR HYPERSENSITIVITY

Interventions

OTHER

No intervention: analysis of health data from patients with

No intervention: analysis of health data from patients with respiratory allergies (asthma, rhinitis), skin allergies (dermatitis, urticarial, angioedema), anaphylaxis, gastrointestinal allergic conditions and ocular allergies (conjunctivitis) for the validation of the chapter allergies and hypersensitivity in the future version of the WHO CIM

Trial Locations (1)

34295

RECRUITING

Uhmontpellier, Montpellier